Clean Harbors Inc (CLH) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock has strong positive catalysts, including bullish technical indicators, hedge fund buying, and improving financial performance. Analysts are optimistic, with recent upgrades and price target increases. The company's growth prospects in hazardous waste disposal and the Safety-Kleen division are supported by favorable industry dynamics. While there are no significant short-term trading signals, the long-term outlook makes this a solid investment opportunity.
The technical indicators for CLH are bullish. The MACD histogram is positive and expanding, indicating upward momentum. The RSI is neutral at 74.906, and the moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200). The stock is trading above key support levels, with resistance at 310.525 and support at 295.474. This suggests a strong upward trend.

Hedge funds are significantly increasing their positions in the stock (+883.21%).
Analysts have upgraded the stock with higher price targets, citing improving U.S. chemicals production and rising crude prices benefiting the Safety-Kleen division.
Strong financial performance in Q4 2025, with revenue, net income, EPS, and gross margin all increasing YoY.
The company is well-positioned to benefit from new PFAS regulations and industry dynamics.
Insiders are neutral, with no significant trading activity in the last month.
The stock's recent price movements are modest, with a pre-market change of -0.19% and regular market change of -0.14%, indicating limited short-term momentum.
In Q4 2025, Clean Harbors reported revenue growth of 4.79% YoY to $1.499 billion. Net income increased by 3.12% YoY to $86.59 million, while EPS grew by 5.16% YoY to $1.63. Gross margin improved to 23.74%, up 5.42% YoY. These metrics highlight consistent growth and strong operational performance.
Recent analyst ratings are highly positive. Citi upgraded the stock to Buy with a price target of $346, citing stronger U.S. chemicals production and valuation upside. Other analysts, including Wells Fargo, UBS, and Raymond James, have raised price targets, with some maintaining Buy or Strong Buy ratings. The consensus reflects optimism about the company's growth prospects and industry positioning.